Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib

Схожие документы

• Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib
  по: Riess, Christin, et al.
  Опубликовано: (2020)
• Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
  по: Riess, Christin, et al.
  Опубликовано: (2020)
• Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies
  по: Christin Riess, et al.
  Опубликовано: (2018-11-01)
• HGG-07. CYCLIN-DEPENDENT KINASES AS TARGET STRUCTURES FOR CANCER THERAPY – A COMPARATIVE IN VITRO ANALYSIS ON PATIENT-DERIVED GLIOBLASTOMA CELL CULTURE MODELS
  по: Riess, Christin, et al.
  Опубликовано: (2020)
• HGG-32. ARG-AUXOTROPHIC PATIENT-DERIVED GLIOBLASTOMA MULTIFORME CELL LINES SHOW INCREASED SENSITIVITY TOWARDS DOXYCYCLINE-INDUCED GROWTH INHIBITION
  по: Shokraie, Fatemeh, et al.
  Опубликовано: (2018)